These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19766456)

  • 1. Aetiopathogenesis of autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive immunity in autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aetiopathogenesis of autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
    Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
    Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
    Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
    J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell immunity in autoimmune hepatitis.
    Ichiki Y; Aoki CA; Bowlus CL; Shimoda S; Ishibashi H; Gershwin ME
    Autoimmun Rev; 2005 Jun; 4(5):315-21. PubMed ID: 15990080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Pediatr Transplant; 2004 Dec; 8(6):589-93. PubMed ID: 15598331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.
    Ma Y; Bogdanos DP; Hussain MJ; Underhill J; Bansal S; Longhi MS; Cheeseman P; Mieli-Vergani G; Vergani D
    Gastroenterology; 2006 Mar; 130(3):868-82. PubMed ID: 16530525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of autoimmune hepatic fibrogenesis induced by an adenovirus encoding the human liver autoantigen cytochrome P450 2D6.
    Hintermann E; Ehser J; Bayer M; Pfeilschifter JM; Christen U
    J Autoimmun; 2013 Aug; 44():49-60. PubMed ID: 23809878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model.
    Yuksel M; Xiao X; Tai N; Vijay M; Gülden E; Beland K; Lapierre P; Alvarez F; Hu Z; Colle I; Ma Y; Wen L
    Clin Exp Immunol; 2016 Nov; 186(2):164-176. PubMed ID: 27414259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.
    Longhi MS; Ma Y; Mitry RR; Bogdanos DP; Heneghan M; Cheeseman P; Mieli-Vergani G; Vergani D
    J Autoimmun; 2005 Aug; 25(1):63-71. PubMed ID: 16005184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators?
    Vierling JM
    Hepatology; 2011 Feb; 53(2):385-8. PubMed ID: 21274860
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of autoimmunity on hepatocytes.
    Vergani D; Mieli-Vergani G
    Semin Liver Dis; 2007 May; 27(2):140-51. PubMed ID: 17520514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis.
    Löhr HF; Schlaak JF; Lohse AW; Böcher WO; Arenz M; Gerken G; Meyer Zum Büschenfelde KH
    Hepatology; 1996 Dec; 24(6):1416-21. PubMed ID: 8938173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune tolerance: what is unique about the liver.
    Tiegs G; Lohse AW
    J Autoimmun; 2010 Feb; 34(1):1-6. PubMed ID: 19717280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of autoimmune hepatitis.
    Liberal R; Longhi MS; Mieli-Vergani G; Vergani D
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):653-64. PubMed ID: 22117632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New animal models for autoimmune hepatitis.
    Christen U; Hintermann E; Jaeckel E
    Semin Liver Dis; 2009 Aug; 29(3):262-72. PubMed ID: 19675999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
    Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
    J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.